AstraZeneca now has a one-stop shop for patients. It's a new all-in-one pharma app that spans the company’s portfolio of drugs, allowing savings card access, refill reminders and customer care contacts across brands.
Called AZHelps, the app extends AstraZeneca’s AZHelps brand from its Twitter customer-care beginnings to a more comprehensive mobile support platform.
Along with the ability to manage AstraZeneca prescriptions, patients can manually add reminders for other non-AZ medications, as well as get information relevant to the conditions they treat. Content partners, including NewsCred and Meredith, will automatically offer specific articles related to the treatments users have registered. A Crestor patient, for instance, might see articles about cholesterol health and managing stress.
“We’re trying to recognize that there are new ways that people are in need of support and that people are looking for support,” said Jenny Streets, senior director, customer experience and innovation at AstraZeneca. “We need to show up in this more contemporary way and do what we’re all trying to do, which is support our patients as they’re trying to work through their healthcare and managing their health.”
The app is meant as a simplicity play rather than a multiple drug patient play, Streets said. Having one AZ app that works for all drugs meant that AZ didn’t have to recreate it across the more than a dozen brands that are included, and it allows patients a one-stop app for the AZ drugs with the ability to add others.
AZ brand available on the app are: Crestor, Symbicort, Farxiga, Seroquel, Brilinta, Bydureon, Byetta, Daliresp, Kombiglyze XR, Nexium, Onglyza, Pulmicort Flexhaler, Tudorza Pressair, and Xigduo XR. It can be downloaded from the Apple app store or Google Play.
“We are trying to be more user-centered in how we approach things,” Streets said.
AstraZeneca will promote AZHelps in a digital marketing campaign with online video and display ads and across social media, where AZHelps channels on Facebook and Instagram have been added to the Twitter handle.
AstraZeneca files Hail Mary petition urging FDA to block more Crestor generics
Valeant, AstraZeneca played the Super Bowl ad game, but did they win?
AstraZeneca chief chalks up milestones on his map to $45B
AstraZeneca launches Nexium direct-to-patient program
Photo courtesy of AstraZeneca